Insiders / Martin Samuel Bates

Martin Samuel Bates

CIK 1709024personinsider

Companies

First seen

Jan 6, 2026

Last activity

Jan 6, 2026

Companies

Company	Role	Shares held	Peak held	Trades	Latest
Celldex Therapeutics, Inc. · CLDX	Executive	32,942	58,815	2	—

2 positions · latest reported per filing

Company	Security	Shares	As of
Celldex Therapeutics, Inc.	Common Stock	32,942	Jan 2, 2026
Celldex Therapeutics, Inc.	Incentive Stock Option (Right to Buy)Derivative	58,815	Jan 2, 2026

InsidersInstitutions

This person's insider trades (Form 4), across every company.

Date	Action	Company	Value	Shares Δ	Position after	Impact
Jan 2, 2026	Exercise	CLDX Celldex Therapeutics, Inc. Common Stock	$50.0K	+5K +17.13%	32,942 0.04% of shares	low
Jan 2, 2026	Exercise	CLDX Celldex Therapeutics, Inc. Incentive Stock Option (Right to Buy)	—	-5K -7.57%	58,815 0.07% of shares	low